The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response

Abstract

MTXGlu remains a potentially useful tool for determining outcomes in patients with JIA being treated with MTX. The genetic predictors of MTXGlu variability may also contribute to a better understanding of the intracellular biotransformation of MTX in these patients.